Molecules 2011, 16(1), 412-426; doi:10.3390/molecules16010412
Review

Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy

Received: 10 November 2010; in revised form: 4 January 2011 / Accepted: 7 January 2011 / Published: 10 January 2011
(This article belongs to the Special Issue Phage Display of Combinatorial Libraries)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Twenty years after its development, antibody phage display using filamentous bacteriophage represents the most successful in vitro antibody selection technology. Initially, its development was encouraged by the unique possibility of directly generating recombinant human antibodies for therapy. Today, antibody phage display has been developed as a robust technology offering great potential for automation. Generation of monospecific binders provides a valuable tool for proteome research, leading to highly enhanced throughput and reduced costs. This review presents the phage display technology, application areas of antibodies in research, diagnostics and therapy and the use of antibody phage display for these applications.
Keywords: antibody; scFv; phage display; cancer; diagnostics; proteome research; panning
PDF Full-text Download PDF Full-Text [251 KB, uploaded 18 June 2014 19:36 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Schirrmann, T.; Meyer, T.; Schütte, M.; Frenzel, A.; Hust, M. Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy. Molecules 2011, 16, 412-426.

AMA Style

Schirrmann T, Meyer T, Schütte M, Frenzel A, Hust M. Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy. Molecules. 2011; 16(1):412-426.

Chicago/Turabian Style

Schirrmann, Thomas; Meyer, Torsten; Schütte, Mark; Frenzel, André; Hust, Michael. 2011. "Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy." Molecules 16, no. 1: 412-426.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert